So like I said 70-100 million market cap. This isn’t a 10 million market cap with 10 million in funding. AGN is 18 months ahead to be exact so like I said phase 2 starts next year in the middle of the year. But drug is de risked come GLP and phase 1 as all pre clinical and studies over the past decade already de risk this drug. Again going to run either way
AGN was a 100 million market cap 2 years ago and to price EV of 0 for NYR is laughable. Just to let you know I’m comfortable and will still be here come FDA and still be here come phase 2 middle of next year and still accumulated more today
So like I said 70-100 million market cap. This isn’t a 10...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 300 | 1 |
View Market Depth
| Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 6.9¢ | 6.9¢ | 15000 | ||
| Last updated 15.16pm 07/06/2024 ? | |||||
| NYR (ASX) Chart |
Day chart unavailable